HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2017
At a glance
- Drugs Boceprevir (Primary) ; Elbasvir/grazoprevir (Primary) ; Ledipasvir/sofosbuvir (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary) ; Sofosbuvir/velpatasvir (Primary) ; Telaprevir (Primary) ; Antivirals; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms HCV-TARGET
- 24 Oct 2017 Results presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases
- 01 May 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
- 01 May 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2018.